Skip to main content
SpringerLink
Log in

Antineoplastics

Development of resistance in non-small-cell lung-cancer : 21 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Iacono D, et al. Intrapatient molecular and histologic heterogeneity after first-generation or second-generation TKI therapy of NSCLC Patients: Potential clinical impact on subsequent third-generation TKI Treatment. American Journal of Clinical Oncology 42: 845-850, No. 11, Nov 2019. Available from: URL: http://doi.org/10.1097/COC.0000000000000615 - Italy

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1782, 38 (2019). https://doi.org/10.1007/s40278-019-72207-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-72207-2

Search

Navigation